Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cellebrite DI (CLBT) Stock Price & Analysis

603 Followers

CLBT Stock Chart & Stats

$12.45$0.07(0.57%)
At close: 4:00 PM EST
$10$12.5$15Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$12.18 - $12.51
52-Week Range
$9.58 - $19.98
Previous Close
$12.38
Volume
N/A
Average Volume (3M)
1.78M
Market Cap
$3.12B
Enterprise Value
$3.27B
Total Cash (Recent Filing)
$442.53M
Total Debt (Recent Filing)
$23.23M
Price to Earnings (P/E)
52.6
Beta
0.66
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
0.09
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Recurring Subscription Model

Subscription revenue now represents the overwhelming majority of sales, supporting recurring customer relationships and better revenue visibility. Continued renewals, product expansions, and ongoing device and cloud updates can reinforce durable revenue generation over the next several quarters.

Strong Profitability And Cash Generation

Very high gross margins, improving adjusted EBITDA guidance, and substantial free cash flow indicate strong underlying economics. This gives Cellebrite capacity to fund product development, support customers, and pursue growth while preserving resilience through execution variability.

Product And Market Expansion

Growth in Defense & Intelligence and early contribution from Genesis, Guardian, and Advanced Unlocks show expansion beyond the core offering. Broader product adoption and public-sector demand can deepen customer relationships and support durable ARR growth.

Bears Say

Lowered Growth Outlook

Lowered ARR and revenue guidance indicates that near-term growth is less predictable than previously expected. The reset reflects execution and timing issues, creating a higher hurdle for management to restore confidence while sustaining the longer-term expansion strategy.

Large-deal Execution Dependence

Dependence on a small number of complex transactions makes quarterly results more sensitive to procurement timing and administrative requirements. This can produce uneven ARR conversion, complicate forecasting, and delay the realization of otherwise healthy customer demand.

Uneven Earnings And Cash-flow History

The sharp shift from prior losses to current profitability demonstrates improving economics but also an uneven operating record. Softer year-over-year free cash flow growth further suggests that earnings quality and cash conversion may remain less consistent during the growth transition.

Cellebrite DI News

CLBT FAQ

What was Cellebrite DI’s price range in the past 12 months?
Cellebrite DI lowest stock price was $9.58 and its highest was $19.98 in the past 12 months.
What is Cellebrite DI’s market cap?
Cellebrite DI’s market cap is $3.12B.
When is Cellebrite DI’s upcoming earnings report date?
Cellebrite DI’s next earnings report is estimated for Nov 12, 2026 (not yet confirmed), which is in 5 days.
How were Cellebrite DI’s earnings last quarter?
Cellebrite DI released its earnings results on Aug 13, 2026. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.062 by -$0.042.
Is Cellebrite DI overvalued?
According to Wall Street analysts Cellebrite DI’s price is currently Undervalued.
Does Cellebrite DI pay dividends?
Cellebrite DI does not currently pay dividends.
What is Cellebrite DI’s EPS estimate?
Cellebrite DI’s EPS estimate is 0.09.
How many shares outstanding does Cellebrite DI have?
Cellebrite DI has 251,341,060 shares outstanding.
What happened to Cellebrite DI’s price movement after its last earnings report?
Cellebrite DI reported an EPS of $0.02 in its last earnings report, missing expectations of $0.062. Following the earnings report the stock price went down -29.18%.
Which hedge fund is a major shareholder of Cellebrite DI?
Hedge funds hold Cellebrite DI shares: the largest hedge-fund position in Cellebrite DI is 71,884,371 shares, and hedge funds increased their holdings by 2.1M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology